These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 659016)
21. Chemotactic activity of venom from the brown recluse spider (Loxoscelles reclusa). Gebel HM; Campbell BJ; Barrett JT Toxicon; 1979; 17(1):55-60. PubMed ID: 419538 [No Abstract] [Full Text] [Related]
22. Location of brown recluse venom attachment sites on human erythrocytes by the firritin-labeled antibody technique. Futrell JM; Morgan PN; Su SP; Roth SI Am J Pathol; 1979 Jun; 95(3):675-82. PubMed ID: 377995 [TBL] [Abstract][Full Text] [Related]
23. Serum amyloid P component: its role in platelet activation stimulated by sphingomyelinase D purified from the venom of the brown recluse spider (Loxosceles reclusa). Gates CA; Rees RS Toxicon; 1990; 28(11):1303-15. PubMed ID: 1965062 [TBL] [Abstract][Full Text] [Related]
25. A new assay for the detection of Loxosceles species (brown recluse) spider venom. Gomez HF; Krywko DM; Stoecker WV Ann Emerg Med; 2002 May; 39(5):469-74. PubMed ID: 11973553 [TBL] [Abstract][Full Text] [Related]
26. Effect of hyperbaric oxygen on sphingomyelinase D activity of brown recluse spider (Loxosceles reclusa) venom as studied by 31P nuclear magnetic resonance spectroscopy. Merchant ML; Hinton JF; Geren CR Am J Trop Med Hyg; 1997 Mar; 56(3):335-8. PubMed ID: 9129539 [TBL] [Abstract][Full Text] [Related]
27. Separation and characterization of venom components in Loxosceles reclusa--III. Hydrolytic enzyme activity. Norment BR; Jong YS; Heitz JR Toxicon; 1979; 17(6):539-48. PubMed ID: 524382 [No Abstract] [Full Text] [Related]
30. Separation and characterization of venom components in Loxosceles reclusa--II. Protease enzyme activity. Jong YS; Norment BR; Heitz JR Toxicon; 1979; 17(6):529-37. PubMed ID: 42990 [No Abstract] [Full Text] [Related]
31. Brown recluse spider (Loxosceles reclusa) envenomation in small animals. Pace LB; Vetter RS J Vet Emerg Crit Care (San Antonio); 2009 Aug; 19(4):329-36. PubMed ID: 25164631 [TBL] [Abstract][Full Text] [Related]
32. Passive hemagglutination inhibition test for diagnosis of brown recluse spider bite envenomation. Barrett SM; Romine-Jenkins M; Blick KE Clin Chem; 1993 Oct; 39(10):2104-7. PubMed ID: 8403394 [TBL] [Abstract][Full Text] [Related]
33. [Hemolysis induced by Loxosceles laeta venom. In vitro experience]. Bravo M; Puratic O; Behn C; Fardella C; Contreras A Rev Med Chil; 1993 Jan; 121(1):16-20. PubMed ID: 8235159 [TBL] [Abstract][Full Text] [Related]
34. Toxicity of two North American Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms. de Roodt AR; Estevez-Ramírez J; Litwin S; Magaña P; Olvera A; Alagón A Clin Toxicol (Phila); 2007 Sep; 45(6):678-87. PubMed ID: 17849243 [TBL] [Abstract][Full Text] [Related]
35. Incompatibility associated with the bite of a brown recluse spider (Loxosceles reclusa). Hardman JT; Beck ML; Hardman PK; Stout LC Transfusion; 1983; 23(3):233-6. PubMed ID: 6407159 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic Plasma Exchange for Refractory Hemolysis After Brown Recluse Spider (Loxosceles reclusa) Envenomation. Abraham M; Tilzer L; Hoehn KS; Thornton SL J Med Toxicol; 2015 Sep; 11(3):364-7. PubMed ID: 26002217 [TBL] [Abstract][Full Text] [Related]
37. [Study of anti-loxosceles serum action on hemolytic and ulcero-necrotic cutaneous effects of Loxosceles laeta venom]. Bravo M; Oviedo I; Farías P; Schenone H Rev Med Chil; 1994 Jun; 122(6):625-9. PubMed ID: 7732205 [TBL] [Abstract][Full Text] [Related]
38. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas. Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571 [TBL] [Abstract][Full Text] [Related]
39. Survey for potentially necrotizing spider venoms, with special emphasis on Cheiracanthium mildei. Foradori MJ; Smith SC; Smith E; Wells RE Comp Biochem Physiol C Toxicol Pharmacol; 2005 May; 141(1):32-9. PubMed ID: 15979415 [TBL] [Abstract][Full Text] [Related]
40. Protection of retroviral vector particles in human blood through complement inhibition. Rother RP; Squinto SP; Mason JM; Rollins SA Hum Gene Ther; 1995 Apr; 6(4):429-35. PubMed ID: 7612700 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]